Title : Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer.

Pub. Date : 2012 Feb

PMID : 22170708






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONTEXT: Abiraterone acetate is a small-molecule cytochrome P450 17A1 (CYP17A1) inhibitor that is active in castration-resistant prostate cancer. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 CONTEXT: Abiraterone acetate is a small-molecule cytochrome P450 17A1 (CYP17A1) inhibitor that is active in castration-resistant prostate cancer. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens
3 RESULTS: Treatment with single-agent abiraterone acetate was associated with accumulation of steroids with mineralocorticoid properties upstream of CYP17A1. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens
4 CONCLUSION: CYP17A1 inhibition with abiraterone acetate is characterized by significant suppression of androgen and cortisol synthesis. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens